[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lateral-femoral-cutaneous-nerve-block\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lateral-femoral-cutaneous-nerve-block":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":4},"100644066","penglfcn-block-vs-qipb-for-total-hip-arthroplasty-100644066",false,"NCT07667231","PENG+LFCN Block vs QIPB for Total Hip Arthroplasty","Comparison Between Quadro-iliac Plane Block (QIPB) and Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve Block for Total Hip Arthroplasty: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Age between 18 and 80 years\n* American Society of Anesthesiologists physical status I-III\n* Scheduled for elective unilateral primary total hip arthroplasty\n* Surgery planned under spinal anesthesia\n* Ability to understand and use the Numeric Rating Scale\n* Written informed consent provided\n\nExclusion Criteria:\n\n* Refusal to participate\n* Revision total hip arthroplasty\n* Bilateral total hip arthroplasty\n* Contraindication to spinal anesthesia\n* Contraindication to peripheral nerve block\n* Known allergy to local anesthetics or study drugs\n* Coagulopathy or anticoagulant use incompatible with neuraxial\u002Fregional anesthesia\n* Infection at the block injection site\n* Pre-existing neurological deficit involving the operative lower extremity\n* Peripheral neuropathy\n* Chronic opioid use\n* Cognitive impairment or inability to communicate reliably\n* Severe hepatic or renal failure\n* Body mass index \\>35 kg\u002Fm²\n* Pregnancy","ALL","18 Years","80 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","This randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve(LFCN) block in patients undergoing total hip arthroplasty. The primary outcome is the Numeric Rating Scale (NRS) within the first 48 hours after surgery. Secondary outcomes include postoperative total opioid consumption, ıncidence of quadriceps motor block, time to first ambulation, block performance time, falls, length of hospital stay, block- related complications(hematoma,local anesthetic systemic complications, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and incidence of postoperative nausea and vomiting.",[27,28,29,30,31],"Quadro-Iliac Plane Block","Pericapsular Nerve Group Block (PENG Block)","Hip Arthroplasty, Total","Pain Management","Lateral Femoral Cutaneous Nerve Block",[33,34,35],"QIPB","PENG","LFCN","NOT_YET_RECRUITING","2026-06-20",{"date":39,"type":40},"2026-06-25","ACTUAL",{"date":42,"type":21},"2026-11-15",{"date":44,"type":21},"2027-09-15",{"name":46,"class":47},"Antalya City Hospital","OTHER",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":68,"leadSponsor":70,"locationsCount":72},"100578326","analgesic-efficacy-of-blocking-nerve-to-vastus-lateralis-muscle-versus-lateral-femoral-cutaneous-nerve-after-knee-surgeries-100578326","NCT06809842","Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries","Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries: A Randomized Trial","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Both sexes.\n* American Society of Anesthesiologists (ASA) physical status from I to III.\n* Underwent knee surgeries under spinal anesthesia.\n\nExclusion Criteria:\n\n* Pregnancy.\n* Coagulopathy.\n* Neuromuscular disorders.\n* Hematological disorders.\n* Mental disorders.\n* History of multiple traumas or anesthesia drug allergies.\n* Local skin infection at the block site.\n* Body mass index (BMI) greater than 40.\n* Opioid analgesics or abusing opioids.",{"count":56,"type":21},80,[24],"This study aims to compare the analgesic efficacy and functional outcomes of blocking the nerve to the vastus lateralis (NVL) muscle versus the lateral femoral cutaneous nerve (LFCN).",[60,61,31,62],"Analgesia","Vastus Lateralis Nerve Block","Knee Surgeries","RECRUITING","2025-02-05",{"date":66,"type":40},"2025-02-06",{"date":64,"type":40},{"date":69,"type":21},"2025-07-30",{"name":71,"class":47},"Kafrelsheikh University",1]